Utah Innovation Fund — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

3Helix3helix.com 𝕏Oct 2023

3Helix develops and sells collagen hybridizing peptides (CHP) and related conjugates for research and diagnostic applications.

BiotechHealthtechMedical DevicesNew MaterialsSalt Lake City, US

Mike Kirkness(CEO)inToby Barrack(VP)inMichael Fugman(Director)Michael Yu(Director)Noah Nasser(Director)

BoardNalini D Kelly(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.